chr9-132903728-G-A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000368.5(TSC1):c.2131C>T(p.Gln711*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. Q711Q) has been classified as Benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000368.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- lung lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000368.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC1 | NM_000368.5 | MANE Select | c.2131C>T | p.Gln711* | stop_gained | Exon 17 of 23 | NP_000359.1 | ||
| TSC1 | NM_001406592.1 | c.2131C>T | p.Gln711* | stop_gained | Exon 17 of 23 | NP_001393521.1 | |||
| TSC1 | NM_001406593.1 | c.2131C>T | p.Gln711* | stop_gained | Exon 17 of 23 | NP_001393522.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC1 | ENST00000298552.9 | TSL:1 MANE Select | c.2131C>T | p.Gln711* | stop_gained | Exon 17 of 23 | ENSP00000298552.3 | ||
| TSC1 | ENST00000490179.4 | TSL:3 | c.2131C>T | p.Gln711* | stop_gained | Exon 18 of 24 | ENSP00000495533.2 | ||
| TSC1 | ENST00000643875.1 | c.2131C>T | p.Gln711* | stop_gained | Exon 17 of 23 | ENSP00000495158.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Tuberous sclerosis 1 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in TSC1 are known to be pathogenic (PMID: 10227394, 17304050). This variant has been reported in individuals in the Leiden Open-source Variation Database (PMID: 21520333). ClinVar contains an entry for this variant (Variation ID: 48907). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln711*) in the TSC1 gene. It is expected to result in an absent or disrupted protein product.
Tuberous sclerosis syndrome Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at